z-logo
open-access-imgOpen Access
A novel Fe 3 O 4 magnetic nanoparticles functionalized by glutamic acid and conjugated with thiosemicarbazide alter the expression of norB gene, in Staphylococcus aureus
Author(s) -
Safarnejad Erfan,
MoradiShoeili Zeinab,
Rahmatollahi Hamid Reza,
Jalali Amir,
Salehzadeh Ali
Publication year - 2022
Publication title -
micro and nano letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.25
H-Index - 31
ISSN - 1750-0443
DOI - 10.1049/mna2.12109
Subject(s) - staphylococcus aureus , conjugated system , chemistry , nanoparticle , magnetic nanoparticles , microbiology and biotechnology , nuclear chemistry , bacteria , nanotechnology , materials science , biology , organic chemistry , polymer , genetics
Here, the improved efficacy of a novel composite of iron oxide (Fe 3 O 4 ) magnetic nanoparticles (MNPs) functionalized by glutamic acid (Glu) and conjugated with thiosemicarbazide (TSC), evaluated on the expression of norB efflux pump gene in S. aureus strains. The proper synthesis of Fe 3 O 4 @Glu–TSC NP was confirmed and characterized by Fourier transform infrared spectroscopy (FTIR), scanning and transmission electron microscopy, Brunauer–Emmett–Teller (BET), energy dispersive X‐Ray spectroscopy (EDX), X‐ray diffraction (XRD), and UV–vis spectroscopy. The effect of NP on the expression of norB gene was studied using quantitative reverse transcription polymerase chain reaction (qRT‐PCR). The physical analysis of NP revealed proper synthesis, dispersion, and stability, as well as the spherical/cubic morphology with a mean size of 35–60 nm. The minimum inhibitory concentration (MIC) value of the functionalized nanoparticle decreased by two folds towards each respected strain in contrast with the Fe 3 O 4 NP (alone). Additionally, in the presence of NP, the norB gene expression was reduced by up to 50% in comparison with the control group. In conclusion, the functionalized NP can be considered as a promising inhibitor of bacterial efflux pump genes against antibiotic‐resistant bacteria. However, further studies should be conducted to determine the safety of these nanoparticles for medicinal applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom